Week of September 27, 2022 | Vol. 11, Issue 38


In This Issue

Upcoming Events

Industry M&A Activity

Recent Transactions

Trading Comps

Market Reports

M&A Pipeline

Featured Headlines

Tanner Updates

Quick Links

Who We Are

M&A Discussion Group

Daybreak Consumer Care

Carlin Consumer Health

Contact Information

Xan Smith

Managing Director

Business Development


Jeremy C. Johnson

Managing Director

Head of M&A and Capital Advisory


Industry Snapshot
Above is an overview of recent industry M&A activity. Click on the chart to view complete transaction tables broken out by industry sub sectors. For additional information, see the Industry M&A Activity section below.
Events Hosted or Attended by Bourne Partners
October 12, 2022 - Charlotte, NC
October 24-26, 2022 - Leipzig, Germany
November 1-3, 2022 - Messe Frankfurt, Germany
Recent Transactions, Trading Comps, Market Reports, M&A Pipeline
An Overview of Transactions Within Market Sub-segments
Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.

Pharma & Biotech

8 transactions totaling $277 million

Supplies, Equipment & Services

15 transactions totaling $1,399 million

Healthcare IT & Managed Care

7 transactions $929 million

Healthcare Facilities & Distributors

13 transactions totaling $780 million


Pharma & Biotech

21 transactions totaling $283 million

Supplies, Equipment & Services

24 transactions totaling $276 million

Healthcare IT & Managed Care

15 transactions totaling $71 million

Healthcare Facilities & Distributors

4 transactions


Pharma & Biotech

17 transactions totaling $687 million

Supplies, Equipment & Services

8 transactions totaling $135 million

Healthcare IT & Managed Care

2 transactions totaling $155 million

Healthcare Facilities & Distributors

2 transactions

A Breakdown of Relevant Trading Multiples
This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.

Insight Into Healthcare Related Industries

Pharma Services Sector Snapshot 1H 2022

August 2022

Consumer Health Sector Snapshot Q2 2022

June 2022


Representative Current Retained Sell-Side And Partnering Opportunities

Project Beach

Sell-Side |Pharma Services| Clinical Trial Services Provider

Project Ester

Sell-side |Pharma| OTC Technology and Products Developer

Project Gateway

Sell-Side |Pharma| Generic Pharmaceuticals

Project Jazz

Sell-Side |Pharma Services| Compounding Pharmacy and Pharmacy Service Provider

Project Panther

Sell-Side| CDMO | Consumer Health and Medical Device

Project Power Play

Buy-Side | Specialty Pharma |Branded & Generic Pharmaceuticals

Project S

Sell-side |Pharma Services | Compounding Pharmacy and Telehealth Platform

Project Trident

Buy-Side | Generic Pharma | Manufacturing liquid generics


A Sampling of Industry Headlines

Hoth Therapeutics Announces Partnership with Altasciences for Manufacturing HT-TBI for Traumatic Brain Injury and Stroke

Hoth Therapeutics - September 20, 2022

Shuttle Pharmaceuticals Enters into Manufacturing Agreement for Ropidoxuridine

PR Newswire - September 20, 2022

Emyria teams with CRO PsychoGenics for MDMA-like drug development

Fierce Biotech - September 21, 2022

Thermo Fisher Scientific Partners with Pennsylvania Biotechnology Center to Support Life Sciences Growth in Philadelphia

Business Wire - September 21, 2022

Cognizant's clinical study platform hits quarter-million user milestone

Fierce Biotech - September 22, 2022

Danaher merging Cytiva and Pall to create $7.5bn bioprocess juggernaut

BioProcess International - September 22, 2022

Alcami Adds Solid-State Characterization Capabilities

PR Newsire - September 22, 2022

Emercell and Cell-Easy Sign a Strategic Agreement for the Scale-up and Manufacturing of NK-001

Business Wire - September 22, 2022

Bora and TaiRx to manufacture anticancer drug

Manufacturing Chemist - September 23, 2022



Overcoming Procurement and Supply Chain Challenges in Clinical Trials

The global pandemic has had a significant impact on clinical trials, forcing operators to alter their processes. Discover how TannerCTS is helping partners overcome these new challenges and ensure supply continuity from EVP of Clinical Services, Georg Schulz.

Navigating Registration and Commercialization Processes in Latin America

Latin America boasts large patient populations with high demand for world-class products, and the #pharma market is growing rapidly, but commercialization processes can be complex. Learn more about how TannerLAC is easing this burden for pharma manufacturers.

Let's Connect!
The Tanner team will be attending several networking events in the coming weeks. Let’s connect to discuss how our organizations can improve patient lives, together.